MXCT
MaxCyte, Inc.
Medical Devices · Healthcare · United States
1.59
close · 2026-10-30
value
21
cheaper than peers21
quality
19
stronger fundamentals19
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 1.06× | 81 |
| earnings yield, 3 years ago | -14.5% | 41 |
| earnings yield, 1 year ago | -24.5% | 35 |
| earnings yield, 2 years ago | -23.3% | 35 |
| cash flow yield, 2 years ago | -15.5% | 33 |
| earnings yield, latest year | -26.4% | 29 |
| cash flow yield, 3 years ago | -20.3% | 28 |
| cash flow yield, 1 year ago | -17.8% | 27 |
| price to sales | 5.28× | 23 |
| cash flow yield, latest year | -22.0% | 21 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 10.9% | 74 |
| return on equity | -20.4% | 47 |
| operating margin | -140.7% | 9 |
| revenue growth | -14.5% | 8 |
4 of 4 measures available
Facts
| market cap | $164M |
| free cash flow | -$13.1M |
| employees | 91 |
| first trade | 2021-07-30 |
| next earnings | 2026-11-10 |
| fundamentals updated | 2026-08-20 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.42 | -0.39 | -0.37 | -0.23 |
| free cash flow | -$36.2M | -$29.3M | -$25.4M | -$33.3M |
| net income | -$44.6M | -$41.1M | -$37.9M | -$23.6M |
| revenue | $33.0M | $38.6M | $41.3M | $44.3M |
| unusual items | -$6.6M | $0 | not reported | not reported |